4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-18-027373
CIK 0001652130other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:35 PM ET
Size
5.5 KB
Accession
0001209191-18-027373
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (right to buy)
2018-05-01+23,500→ 23,500 totalExercise: $20.56Exp: 2028-04-30→ Common Stock (23,500 underlying)
Footnotes (1)
- [F1]This option was granted on May 1, 2018 with respect to 23,500 shares of Common Stock, with 25% vesting on May 1, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:35 PM ET
- Size
- 5.5 KB